14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks

6. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q2 2025: 119

Even though Eli Lilly and Company (NYSE:LLY)’s shares have lost 6.9% year-to-date, Cramer continues to be a believer in the stock. He believes that the firm is establishing a strong manufacturing presence in the US and outlined that his “original prediction” of the firm becoming the first $1 trillion non-tech company could be wrong given recent headwinds. Here are Cramer’s latest thoughts about Eli Lilly and Company (NYSE:LLY):

“Lilly’s already putting up plants for pills. Which is pretty amazing. The holy grail would be a pill that did not take away from protein and continue to just go after fat. Lilly is doing that. I think that that’s why they’re so far ahead. You know, Carl, Lilly has been, I was doing a bottle signing for my wife. . .people are like, you know this Lilly, nothing’s happening there. It’s been one of the greatest performers ever. It’s become a what have you done for me lately story. Which means they have to win some sort of, there has to be a new trial that somehow gets people excited again. Whether it be for some disease we don’t know, Alzheimer’s perhaps, congestive heart failure. And if it doesn’t get that then I think people, you know what, I wanna move on to the next one. And that’s pretty amazing.

“[In response to Carl asking whether the obesity weight loss story was not enough to carry the stock in the long term] Not anymore, no, that’s why the stock has stalled. And I, look I’m a David Ricks believer. I think that’s a mistake. I tell people you gotta stick with Eli Lilly. I would not trade it. But I recognize when there’s a stock that has stalled. And people feel that this is a, this administration could take a negative look on it.”